<DOC>
	<DOCNO>NCT01228461</DOCNO>
	<brief_summary>Fatigue one prevalent symptom endorse cancer survivor , particularly treat breast cancer Hodgkin lymphoma . Despite tremendous implication work effective intervention , little known underlie pathophysiology fatigue , association medical co-morbidities factor may help predict high risk . The propose research utilize Vanderbilt-Ingram Cancer Center REACH Survivorship Program together investigator Hematologic Malignancies Program . In adolescent young adult ( AYA ) , age 18 - 39 investigator address following : Primary Aims Aim 1 : Assess prevalence severity fatigue impact functional outcome Aim 2 : Determine host , disease treatment-related risk factor fatigue Secondary Aims Aim 1 : Evaluate association level proinflammatory cytokine activity fatigue Aim 2 : Evaluate association fatigue self report fatigue AYA Hodgkin lymphoma ( HL ) survivor . Hypotheses : 1 . Fatigue prevalent severe among AYA HL patient survivor , compare general population associate impaired functional outcome . 2 . Risk factor fatigue include high disease stage , B symptom elevate erythrocyte sedimentation rate diagnosis , dose density chemotherapy high dos expand field radiotherapy . 3 . Risk fatigue associate long-term cardiopulmonary endocrine complication . 4 . Levels specify proinflammatory cytokine associate increase fatigue .</brief_summary>
	<brief_title>Risk Fatigue Adolescent Young Adult Hodgkin Lymphoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>Currently 18 year age older Alive without evidence recurrent disease Must therapy ( active treatment HL malignancy ) Must form chemotherapy ( oral intravenous [ IV ] ) Provide inform consent Can read understand English Treated riskadapted therapy may include radiotherapy dos &lt; 30 Gy Evidence subsequent malignancy follow lymphoma treatment</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hodgkin Lymphoma Survivors</keyword>
	<keyword>Adolescent Young Adults</keyword>
</DOC>